| Literature DB >> 34430749 |
Tikuneh Yetneberk1, Basazinew Chekol1, Diriba Teshome1.
Abstract
BACKGROUND: Controversy still exists regarding the analgesic efficacy of transverse abdominis plane (TAP) block versus ilioinguinal or iliohypogastric (IL/IH) nerve block for postoperative pain management following cesarean section. This meta-analysis aimed to perform relatively credible pooled results on the efficacy of the TAP versus IL/IH nerve block for postoperative pain management after cesarean section.Entities:
Keywords: Cesarean section; IL/IH block; Meta-analysis; TAP block
Year: 2021 PMID: 34430749 PMCID: PMC8367791 DOI: 10.1016/j.heliyon.2021.e07774
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1PRISMA flow diagram showing search strategies.
Characteristics of studies included in the systematic review and meta-analysis of the efficacy of TAP block versus ilioinguinal block for post-cesarean section pain management, 2021.
| Author | Publication year | Study design | Sample size (TAP, IL/IH) | Type of anesthesia | Nerve block approach | TAP dose | IL/IH dose | The postoperative pain management protocol | Quality of evidence |
|---|---|---|---|---|---|---|---|---|---|
| S. Abiy et al. [ | 2020 | RCT | 36,36 | Spinal | Land mark | 40 ml of 0.25 % of bupivacaine | 32 ml of 0.25 % of bupivacaine | Tramadol IV, 1 mg/kg, pethidine IM PRN | High |
| Ahemed et al. [ | 2018 | Cohort | 51,51 | Spinal | Land mark | 40 ml of 0.25 % of bupivacaine | 32 ml of 0.25 % of bupivacaine | No protocol | High |
| Kiran, et al. [ | 2017 | RCT | 30,30 | Spinal | Ultrasound guided | 40 ml of 0.25 % of bupivacaine | 20 ml of 0.25 % of bupivacaine | 1gramIV, paracetamol, 50mgIV, diclofenac | High |
| Roshbeik MY et al. [ | 2021 | RCT | 17,15 | Spinal | Ultrasound guided | 20 ml of 0.5 % of bupivacaine | 20 ml of 0.5 % of bupivacaine | No protocol | High |
| JIN et al. [ | 2019 | Cohort | 62,62 | CSE | Ultrasound guided | 20 ml, 0.375 % ropivacine or 0.3 % levobupivacine | 20 ml,0.375 % ropivacine or 0.3 % levobupivacine | PCA and supplementary morphine | High |
CSE: Combined spinal-epidural, IV: Intravenous, IL/IH: Ilioinguinal/Iliohypogastric, PCA: Patient control analgesia, RCT: Randomized control trial, TAP: Transversus abdominis plane.
Figure 2Time to first rescue analgesia request in minute.
Figure 3Subgroup analysis by nerve block techniques.
Figure 4Subgroup analysis by study design.
Figure 5Intravenous equivalent total tramadol consumption at 24 h postoperatively.
Figure 6Intravenous equivalent total tramadol consumption at 48 h postoperatively.
The mean difference of pain severity score at rest between TAP and IL/IH nerve block.
| Time of measurement | Number of studies | Heterogeneity with I2, p-value | MD with 95%CI | p-value |
|---|---|---|---|---|
| At 2 h | 3 | 0.00 %, 0.77 | -0.10 (-0.46–0.26) | 0.60 |
| At 4 h | 5 | 74.52 %, 0.001 | -0.10 (-0.55–0.35) | 0.66 |
| At 6 h | 4 | 82.7 %, 0.001 | -0.20 (-0.74–0.34) | 0.46 |
| At 8 h | 4 | 82.37 %, 0.001 | 0.16 (-0.45–0.76) | 0.61 |
| At 12 h | 4 | 82.37 %, 0.001 | 0.16 (-0.45–0.76) | 0.61 |
| At 24 h | 5 | 38.96 %, 0.16 | 0.16 (-0.08–0.41) | 0.19 |
| At 48 h | 2 | 98.89 %, 0.001 | -0.07 (-3.66–3.51) | 0.97 |
CI: Confidence interval, MD: Mean difference.
The mean difference of pain severity score at movement between TAP and IL/IH nerve block.
| Time of measurement | Number of studies | Heterogeneity with I2, p-value | MD with 95%CI | p-value |
|---|---|---|---|---|
| At 2 h | 2 | 89.86 %, 0.001 | -0.48 (-1.46–0.5) | 0.33 |
| At 4 h | 2 | 89.86 %, 0.001 | -0.48 (-1.46–0.5) | 0.33 |
| At 6 h | 3 | 77.57 %, 0.01 | 0.53 (-0.08–1.14) | 0.09 |
| At 8 h | 4 | 60.2 %, 0.05 | 0.33 (-0.12–0.77) | 0.15 |
| At 12 h | 4 | 95.29 %, 0.001 | 0.14 (-0.83–1.11) | 0.78 |
| At 24 h | 4 | 95.29 %, 0.001 | 0.14 (-0.83–1.11) | 0.78 |
CI: Confidence interval, MD: Mean difference.